Bionano Genomics, Inc. is a life sciences company that develops genomic analysis tools designed to help researchers and clinicians detect large-scale structural variations in DNA. Its technology is intended to complement or extend conventional sequencing and cytogenetic methods by providing information about changes in genome structure, including deletions, duplications, inversions and translocations.
The company’s principal platform is the Saphyr system, an optical genome mapping solution that analyzes ultra-high-molecular-weight DNA. The platform combines specialized instrumentation, consumables and software to create detailed maps of genomes. Bionano also offers analysis and interpretation software, including tools associated with its BioDiscovery business, as well as workflow and data-analysis services for research, translational and clinical applications.
Bionano’s products are used by academic institutions, research organizations, biopharmaceutical companies, hospitals and clinical laboratories in areas such as cancer research, constitutional genetics, reproductive health and rare-disease investigation. Founded in 2003 and headquartered in San Diego, California, the company has expanded its offerings through acquisitions, including BioDiscovery and Lineagen, to provide genomic data analysis and testing capabilities alongside its optical genome mapping technology.
AI Generated. May Contain Errors.
